Public limited company · Wavre · incorporated on 05/04/2012 · 213,4 ETP
| 2025 | 2024 | 2023 | 2018 | 2017 | 2016 | 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 265,6 M € | +13.9% | 233,2 M € | +20.6% | 193,3 M € | -3.6% | 200,6 M € | +8.9% | 184,2 M € | +6.9% | 172,3 M € | +0.9% | 170,7 M € | |
| EBITDA | 12,5 M € | +9.7% | 11,4 M € | +26.7% | 9,0 M € | +12316.4% | -73,7 k € | +99.3% | -11,3 M € | -20.9% | -9,3 M € | -426.2% | -1,8 M € | |
| Operating profit | 9,0 M € | +18.9% | 7,6 M € | +16.5% | 6,5 M € | +942.4% | -770,5 k € | +93.8% | -12,5 M € | -18.1% | -10,6 M € | -236.7% | -3,1 M € | |
| Profit/loss | 6,4 M € | -3.0% | 6,6 M € | +5.9% | 6,3 M € | +396.0% | -2,1 M € | -104.9% | 43,2 M € | -23.4% | 56,4 M € | +1346.4% | -4,5 M € | |
| Equity | 182,7 M € | -1.5% | 185,6 M € | -4.8% | 194,9 M € | +152.0% | 77,4 M € | -2.7% | 79,5 M € | +1.6% | 78,2 M € | +6.4% | 73,6 M € | |
| Total assets | 227,4 M € | -1.8% | 231,4 M € | -3.4% | 239,5 M € | +106.3% | 116,1 M € | -5.1% | 122,4 M € | -4.1% | 127,6 M € | +20.4% | 105,9 M € | |
| Cash | — | — | 52,9 k € | — | — | — | 2,5 M € | |||||||
| Debts | 41,4 M € | -5.4% | 43,8 M € | -0.2% | 43,9 M € | +19.0% | 36,8 M € | -11.4% | 41,6 M € | -15.1% | 49,0 M € | +52.4% | 32,2 M € | |
| Staff | 213,4 | 200,8 | 191,3 | 142,6 | 147,2 | 148 | 148,5 | |||||||
Public limited company profitable and well capitalised. Cash position declining (-97.9%).
Solid counterparty for a standard engagement.
ABBVIE is a Public limited company incorporated in 2012. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Wavre. It employs on average 213,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette